Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis
Czaja, Albert J.

Alimentary Pharmacology & Therapeutics | March 14, 2014 | Volume: 39 | Issue: 10 | Pages: 1043-1058

10.1111/apt.12701 | PMID 24628539 Get It

SummaryBackgroundAutoimmune hepatitis can be rendered treatment‐free, but the difficulty, frequency and risks associated with the pursuit of this outcome are unclear.AimTo describe the frequency that autoimmune hepatitis can be rendered treatment‐free, identify the features that characterise these patients, examine the pathogenic pathways that may sustain or terminate the disease and indicate management protocols that can obtain this result.MethodsStudies cited in Pub Med from 1972–2014 for autoimmune hepatitis, treatment, relapse, remission and outcome were selected.ResultsThe frequency of a treatment‐free state varies from 19% to 40% in patients observed for ≥3 years after drug withdrawal. Complete laboratory resolution and reversion to normal liver tissue prior to drug withdrawal favours this response. The development of cirrhosis during therapy may increase treatment‐dependence. Persistent liver damage and the generation of neo‐antigens during the apoptosis of hepatocytes may perpetuate the disease. Genetic and age‐related effects on the vigour of the immune response may also contribute. Reversion to normal liver tissue is achieved in only 22% of patients during conventional corticosteroid therapy, and the emerging pharmacological and biological interventions may improve this frequency. A management strategy designed to achieve a treatment‐free state accommodates all candidates for this outcome, and it can be modified to a long‐term maintenance strategy as warranted by the clinical response.ConclusionsPermanent drug withdrawal is a treatment outcome that is desirable and achievable in patients with autoimmune hepatitis. Normalisation of liver tests and liver tissue during treatment enhances this occurrence.
Enhanced pain-induced activity of pain-processing regions in a case-control study of episodic migraine
Schwedt, Todd J. , Chiang, Chia‐Chun , Baxter, Leslie C. , Schlaggar, Bradley L. , Chong, Catherine D. , Baxter, Leslie C. , Dodick, David W. , Chiang, Chia-Chun , Schwedt, Todd J

Cephalalgia | March 14, 2014 | Volume: 34 | Issue: 12 | Pages: 947-958

10.1177/0333102414526069 | PMID 24627432 Get It

Objective The objective of this study was to identify brain regions having aberrant pain-induced activation in migraineurs, thereby gaining insight into particular aspects of pain processing that are atypical in migraineurs. Methods Functional magnetic resonance imaging assessed whole brain responses to painful heat in 24 adult episodic migraineurs who were at least 48 hours pain free and 27 healthy controls. Regions differentially activated in migraineurs compared to controls were identified. Activation intensities in these regions were correlated with headache frequency, number of migraine years, and time to next migraine attack. Results Migraineurs had greater pain-induced activation of lentiform nucleus, fusiform gyrus, subthalamic nucleus, hippocampus, middle cingulate cortex, premotor cortex, somatosensory cortex, and dorsolateral prefrontal cortex, and less activation in precentral gyrus and superior temporal gyrus. There were significant correlations between activation strength and headache frequency for middle cingulate ( r = 0.627, p = 0.001), right dorsolateral prefrontal cortex ( r = 0.568, p = 0.004), left fusiform gyrus ( r = 0.487, p = 0.016), left precentral gyrus ( r = 0.415, p = 0.044), and left hippocampus ( r = 0.404, p = 0.050) and with number of migraine years for left fusiform gyrus ( r = 0.425, p = 0.038). There were no significant correlations between activation strength and time to next migraine attack. Conclusions The majority of regions with enhanced pain-induced activation in headache-free migraineurs participate in cognitive aspects of pain perception such as attending to pain and pain memory. Enhanced cognitive pain processing by migraineurs might reflect cerebral hypersensitivity related to high expectations and hypervigilance for pain.
Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end‐stage liver disease and normal serum creatinine awaiting liver transplantation
Corey, Rebecca, Whitaker, Michael , Crowell, Michael D. , Keddis, Mira T. , Aqel, Bashar , Balan, Vijayan , Byrne, Thomas , Carey, Elizabeth J. , Douglas, David D., Harrison, M. Edwyn , Vargas, Hugo E. , Rakela, Jorge , Corey, Rebecca L, Aqel, Bashar A. , Crowell, Michael D , Vargas, Hugo E

Clinical Transplantation | March 13, 2014 | Volume: 28 | Issue: 5 | Pages: 579-584

10.1111/ctr.12351 | PMID 24628047 Get It

AbstractVitamin D deficiency is common among patients with end‐stage liver disease (ESLD). The primary aim of our study was to assess the prevalence of vitamin D deficiency, secondary hyperparathyroidism, and bone disease in patients with ESLD awaiting LT.MethodsWe retrospectively studied 190 patients at our center. Serum total 25‐hydroxyvitamin D (25‐OH D), parathyroid hormone (PTH), calcium, and bone mineral analysis (BMA) were recorded. Standard World Health Organization (WHO) criteria were used to diagnose osteopenia/osteoporosis. Only patients with normal serum creatinine were analyzed.ResultsThirty‐two of 190 patients were excluded from the final analysis (missing serum total 25‐OH D levels in three patients and elevated serum creatinine, 29 patients). 105 of 158 (66.4%) evaluable patients had 25‐OH D levels <25 ng/mL. Patients included in the analysis (n = 158) were divided according to serum total 25‐OH D levels: 0–10 ng/mL (n = 23), 11–20 ng/mL (n = 64), and >20 ng/mL (n = 71). There were no significant differences in mean serum PTH and corrected calcium levels among the three subgroups. Only three patients had elevated serum PTH. Patients with total 25‐OH D ≤ 10 ng/mL had higher model for end‐stage liver disease (MELD) scores vs. those with 25‐OH D > 20 ng/mL (13.3 ± 3, range 8–21, vs. 11.9 ± 3.4, range 6–29, p = 0.004). Irrespective of vitamin D status, bone disease was present in 64.6% of patients.ConclusionLow vitamin D levels and bone disease are common among patients with ESLD awaiting LT. Despite a high prevalence of low serum total 25‐OH D, our cohort maintained normal corrected calcium levels and did not develop secondary hyperparathyroidism. We propose that free serum 25‐OH D and vitamin D‐binding protein may be necessary to accurately establish the diagnosis of vitamin D deficiency in the setting of ESLD. Additional studies are needed to further define mechanisms of bone disease in patients with ESLD.
Thiopurine Pharmacogenomics: Association of Snps with Clinical Response and Functional Validation of Candidate Genes
Matimba, Alice , Li, Fang , Livshits, Alina, Cartwright, Cher, Scully, Stephen, Jenkins, Gregory D. , Batzler, Anthony , Wang, Liewei , Weinshilboum, Richard M. , Lennard, Lynne, Scully, Stephen, Fridley, Brooke L. , Weinshilboum, Richard M.

Pharmacogenomics | March 13, 2014 | Volume: 15 | Issue: 4 | Pages: 433-447

10.2217/pgs.13.226 | PMID 24624911 Get It

CFD Study of the Relationship Between Wall Shear Stress and Aspect Ratio in Elastase Induced Rabbit Aneurysm Models
Zeng, Zijing, Zakaria, Hasballah , Kadirvel, Ramanathan , Ding, Yong-Hong, Lewis, Debra A., Kallmes, David F. , Ding, Yonghong , Robertson, Anne M.

ASME 2008 Summer Bioengineering Conference, Parts A and B | March 13, 2014 | Volume: No volume available | Issue: No issue available | Pages: 35-36

10.1115/sbc2008-193139 Get It

Hemodynamic factors are thought to play an important role in the initiation, growth, and rupture of cerebral aneurysms. In-vitro studies have demonstrated a correlation between the magnitude and distribution of wall shear stress (WSS) and biological response of both endothelial cells and smooth muscle cells [1–3]. In elastase induced saccular aneurysms, low WSS (below 0.5 Pa) was found to have a correlation with altered expression of biological markers [4]. Localized regions of rapid aneurysm growth in-vivo have been shown to be associated with regions where WSS is below a critical value of 0.1 Pa [5]. Further, aspect ratio (AR), the ratio of the maximum diameter of the aneurysm to the width of the aneurysm neck, has been correlated with elevated risk of rupture [6]. The purpose of the current study is to explore the possibility of creating elastase induced aneurysms in rabbits with a range of aspect ratios (ratio of aneurysm height/neck) and evaluate the existence of a correlation between aspect ratio and WSS distribution. Aneurysms with ARs from 0.98 to 2.8 were created at the origin of the right common carotid artery (n = 30). Qualitative differences in WSS distribution were found in the high AR aneurysms (HARA) (AR>1.6) and low AR aneurysms (LARA) (AR<1.6) [7].
Tensile Material Properties of Skeletal Muscle Tissue in Longitudinal and Transverse Directions
Morrow, Duane A., Donahue, Tammy L. Haut , Odegard, Gregory M. , Kaufman, Kenton R.

ASME 2008 Summer Bioengineering Conference, Parts A and B | March 13, 2014 | Volume: No volume available | Issue: No issue available | Pages: 1027-1028

10.1115/sbc2008-193043 Get It

Since Blix noted that force varies with muscle length [1], many investigators have worked to characterize the passive length-tension properties of skeletal muscle in the tissue’s fiber direction [2]. However, few reports have examined the properties of muscle in either transverse extension or in longitudinal shear [3–4]. Material properties in these three directions are needed to fully characterize computational models, which generally describe muscle as being transversely isotropic, hyperelastic, and isovolumetric [3–6]. Further, previous studies reporting tri-planar material properties indicate that muscle tissue is stiffer in the transverse direction compared to the longitudinal direction [3–4]. This counters conventional notions of transversely isotropic materials, which are generally stiffer in the fiber direction.
Experimental Validation of a Tibiofemoral Model for Analyzing Joint Force Distribution
Miller, Emily J. , Reimer, Rose F., Donahue, Tammy L. Haut , Kaufman, Kenton R.

ASME 2008 Summer Bioengineering Conference, Parts A and B | March 13, 2014 | Volume: No volume available | Issue: No issue available | Pages: 767-768

10.1115/sbc2008-192775 Get It

Mathematical models are non-invasive tools used for analyzing biomechanical conditions. Various models of the knee using the finite element analysis technique [1–6] and rigid body spring model (RBSM) [7] have been developed to predict pressure distribution in articulating joints, although the RBSM is considered the simplest of the modeling techniques, while still effectively predicting load distribution. These models can be used to study altered joint loading, which causes a degeneration of the articular cartilage, in order to gain an understanding of the etiology of osteoarthritis (OA). The purpose of this study is to develop a subject-specific analytical knee model using the RBSM approach that incorporates subject-specific geometry, joint health, and loading patterns to predict tibiofemoral load distributions.
Mycoplasma pneumonia-associated mucositis
Varghese, Cyril , Sharain, Korosh , Skalski, Joseph H. , Ramar, Kannan

BMJ Case Reports | March 13, 2014 | Volume: 2014 | Issue: No issue available | Pages: bcr2014203795

10.1136/bcr-2014-203795 | PMID 24626386 Get It

We present a case of a young man with severe mucositis following an upper respiratory tract infection limited to the ophthalmic and oral mucosa while sparing the rest of the skin, genitalia and perianal regions. Investigations revealed that the mucositis was a rare extrapulmonary manifestation of Mycoplasma pneumoniae infection. He had progressive vision-threatening symptoms despite antibiotics and best supportive care and thus was treated with intravenous corticosteroids, immunoglobulins, temporary ocular amniotic membrane grafts and tarsorrhaphy. The patient made an almost complete recovery over 6 weeks.
Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients
Marcelin, Jasmine R , Wilson, John , Razonable, Raymund R. , Marcelin, Jasmine

Transplant Infectious Disease | March 13, 2014 | Volume: 16 | Issue: 2 | Pages: 242-250

10.1111/tid.12194 | PMID 24621016 Get It

AbstractBackgroundRespiratory syncytial virus (RSV) infections may be fatal in immunocompromised patients. Aerosolized ribavirin is used for treatment, but it is very costly, teratogenic, and inconvenient. We aimed to assess the outcome of oral ribavirin treatment, with or without intravenous immunoglobulin (IVIG), for RSV infections in moderately to severely immunocompromised patients.MethodsMedical records of RSV polymerase chain reaction (PCR)‐positive patients during 2011–2013 were reviewed retrospectively. Eligible patients were moderately to severely immunocompromised and received oral ribavirin (600–800 mg twice daily) with or without IVIG (500 mg/kg q 48 h) as per protocol.ResultsOf 96 adults with PCR‐proven RSV infection, 34 were moderately to severely immunocompromised and received oral ribavirin treatment. The mean age was 56.2 years (range: 18–90); 21 were male. Underlying conditions were hematologic malignancy with or without hematopoietic stem cell transplant (n = 25), lung transplant (n = 3), or receipt of cytotoxic chemotherapy (n = 11). The presenting symptoms were cough (94%), fever (62%), and dyspnea (59%). The most common radiographic findings were patchy and nodular infiltrates and opacities. Of 34 patients, 31 were hospitalized, with 13 admitted to the intensive care unit and 6 required mechanical ventilation. The median absolute lymphocyte count on presentation was 480 cells/mm3. RSV pneumonia developed in 24 patients. The median initial duration of oral ribavirin treatment was 10 days (range: 4–11); 4 patients were re‐treated. Of 34 patients, 19 received a mean of 2.7 doses of IVIG. Two patients had adverse reactions to ribavirin (hemolytic anemia and lactic acidosis in 1 patient, and altered mental status in another). No patient died from RSV infection. Three patients died from complications of their underlying illness; all others recovered clinically.ConclusionsOral ribavirin with or without IVIG is a well‐tolerated treatment for RSV infection in moderately to severely immunocompromised hosts. Comparative prospective studies should ideally be performed to determine if oral ribavirin is the optimal therapy for RSV infection in this patient population.